The oversubscription of the Alkem and Dr. Lal Path Labs have created a market that worth Rs. 81000 crores. This is absolutely a great achievement in the history of Indian market. The Alkem IPO was oversubscribed by 44.23 times more than its actual size, whereas in case of the Dr. Lal Path Labs it was 33.31 times more. According to the data available in the Indian market, there was no other company that has got such over subscription ever. Even if any company has got such over subscription, the worth of the oversubscription would have never crossed this.
Alkem lab oversubscription worth Rs. 59000
The IPO of the Alkem lab was oversubscribed by 44.23 times more than its actual size. This oversubscription was a worth of Rs. 59000 crores. The bids received by the company was for 40,18,87,794 shares in total. But the total shares offered by the company to the IPO market was just 90,87,084. This was the data available with the National Stock Exchange by the end of the day. Similar to this the Dr. Lal Path IPO also has got the highest subscription. The oversubscription of Dr. Lal Path was a worth of Rs. 21000 crores.
The total shares offered by the Dr. Lal Path Labs was 81,20,000. But the bids that it has received was for a total of 27,04,74,780 shares. In case of the Alkem labs, the portion of shares that has been set for the qualified institutional buyers was oversubscribed by 57 times more than the actual shares allotted for this category. In case of the retail investors, it was 2.9 times and in case of the high net worth individual category, it was 129 times more than the allotted size of the shares.
Dr. Lal Path Labs oversubscription
In case of the Dr. Lal Path labs, the portion of shares that has been set for the qualified institutional buyers was oversubscribed by 63 times more than the actual shares allotted for this category. In case of the retail investors, it was 4.7 times and in case of the high net worth individual category, it was 52 times more than the allotted size of the shares. Both the company IPOs has got a very high response from the marketers. Especially in the retail investors and institutional investors’ category of IPO, these two companies have faced the highest subscription.
It is already known well that Alkem labs has raised a fund of Rs. 395 crores only from the anchor investors. Before the Alkem labs and the Dr. Lal Path labs, the Power mech projects, VRL logistics and the Syngiene international were the companies that have received the highest response in the IPOs. The marketers have told that the Indian economy is growing and this situation in the Indian market will remain next year also. Hence in the upcoming years, more oversubscriptions can be seen, said some of the market analysts to the reporters. To know more on the recent happenings in initial public offering, follow us at https://twitter.com/TrendsinTrade